Mostrar el registro sencillo del ítem

dc.contributor.authorMendoza, Carmen de
dc.contributor.authorSoriano, Vicente
dc.date2020-03
dc.date.accessioned2020-08-04T14:24:40Z
dc.date.available2020-08-04T14:24:40Z
dc.identifier.issn2352-3018
dc.identifier.urihttps://reunir.unir.net/handle/123456789/10334
dc.description.abstractMedical and social attention to HIV infection has declined globally and is increasingly focused on developing regions, where the epidemic is still largely uncontrolled. In North America and western Europe, AIDS is rarely in newspaper headlines or mentioned in television news. The success of antiretroviral therapy largely explains this change in the perception of HIV/AIDS, which was once a life-threatening disease but is now, more many, viewed as a chronic illness. Indeed, individuals on treatment currently benefit from life expectancies close to those of people who are HIV negative.es_ES
dc.language.isoenges_ES
dc.publisherThe Lancet HIVes_ES
dc.relation.ispartofseries;vol. 7, nº 3
dc.relation.urihttps://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(19)30408-4/fulltextes_ES
dc.rightsrestrictedAccesses_ES
dc.subjectScopuses_ES
dc.subjectJCRes_ES
dc.titleTough requirements for new antiretroviral drugses_ES
dc.typeArticulo Revista Indexadaes_ES
reunir.tag~ARIes_ES
dc.identifier.doihttps://doi.org/10.1016/S2352-3018(19)30408-4


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem